Jefferies Reiterates Buy Rating on Moderna (MRNA)

July 22, 2020 8:45 AM EDT Send to a Friend
Jefferies analyst Michael Yee reiterated a Buy rating and $90.00 price target on Moderna (NASDAQ: MRNA)The analyst comments "PFE/BNTX announced ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login